These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2526246)

  • 21. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
    Anderson G
    J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].
    Sasaki J; Morishima T; Sakamoto H; Takai H; Ikeshima K; Shiiki K; Uematsu M; Morihana T; Tomita F; Noma H
    Jpn J Antibiot; 1989 Apr; 42(4):983-1013. PubMed ID: 2528004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of clarithromycin granule and tablet in children].
    Motohiro T; Yoshinaga Y; Sasaki H; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Sakata Y
    Jpn J Antibiot; 1989 Feb; 42(2):465-94. PubMed ID: 2526257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clarithromycin in the treatment of respiratory infections].
    Med Clin (Barc); 1991 Jun; 97(1):suppl 2 p.. PubMed ID: 1830354
    [No Abstract]   [Full Text] [Related]  

  • 25. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.
    Hardy DJ; Guay DR; Jones RN
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):39-53. PubMed ID: 1530914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Personal experience with erythromycin in the treatment of respiratory tract infections].
    Willeit A; Erckert W; Prunner K
    Minerva Pediatr; 1976 Sep; 28(30):1855-61. PubMed ID: 1012219
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical efficacy of clarithromycin].
    Med Clin (Barc); 1991 Sep; 97(7):suppl 2 p.. PubMed ID: 1834897
    [No Abstract]   [Full Text] [Related]  

  • 28. [Laboratory and clinical investigations of cefodizime in infectious diseases in childhood].
    Komada Y; Arai S; Kamiya H; Sakurai M; Shimizu S; Nishi H; Inoue M; Kojima M; Kawaguchi H; Yoshizumi T
    Jpn J Antibiot; 1989 Jun; 42(6):1346-57. PubMed ID: 2795858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telithromycin: new preparation. A needless addition to the other macrolides.
    Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies of cefodizime in the pediatric field].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Jun; 42(6):1400-13. PubMed ID: 2795864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clarithromycin and azithromycin: new macrolide antibiotics.
    Piscitelli SC; Danziger LH; Rodvold KA
    Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two new macrolide antibiotics: clarithromycin and azithromycin.
    Holdcroft C
    Nurse Pract; 1993 Jan; 18(1):50, 53. PubMed ID: 8380492
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats.
    Kohno Y; Yoshida H; Suwa T; Suga T
    Antimicrob Agents Chemother; 1989 May; 33(5):751-6. PubMed ID: 2526615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experience with cefodizime in pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kouzan H; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Jun; 42(6):1391-8. PubMed ID: 2795863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study on aztreonam in pediatrics].
    Niino M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic use among children in British Columbia, Canada.
    Marra F; Patrick DM; Chong M; Bowie WR
    J Antimicrob Chemother; 2006 Oct; 58(4):830-9. PubMed ID: 16921182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tolerance and efficiency of erythromycin suppositories used in respiratory infections in ambulatory pediatric practice].
    Rodovalho SF
    Hospital (Rio J); 1968 Jun; 73(6):1947-52. PubMed ID: 5306207
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    Vagliasindi M
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.